Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Tracon Pharmaceuticals, Inc. (TCON)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
26 Apr 2023
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
399,417
+14%
50,999
$0.74
$37,889.34
BUY
28 Feb 2023
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
344,918
+1%
5,000
$1.52
$7,600.00
BUY
18 Jan 2023
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
339,918
+2%
6,800
$1.62
$11,016.00
BUY
29 Dec 2022
Brown Scott B.
Chief Financial Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
21,628
+19%
3,500
$1.49
$5,215.00
SELL
21 Dec 2022
LARUE WILLIAM R
Director
Tracon Pharmaceuticals, Inc.
(TCON)
7,763
-1%
120
$1.26
$150.64
BUY
14 Dec 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
333,118
+7%
23,000
$1.29
$29,755.10
BUY
14 Dec 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
4,150,000
+4%
167,500
$1.25
$209,876.50
SELL
6 Dec 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
4,010,000
-0%
1,539
$1.44
$2,216.16
BUY
18 Nov 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
310,118
+4%
13,900
$1.41
$19,599.00
BUY
3 Nov 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
296,218
+3%
9,200
$1.52
$13,984.00
BUY
2 Nov 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
287,018
+2%
6,000
$1.59
$9,540.00
BUY
18 Oct 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,790,000
+0%
12,500
$1.65
$20,625.00
BUY
7 Oct 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
277,518
+1%
5,000
$1.77
$8,850.00
BUY
3 Oct 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
272,518
+1%
5,000
$1.67
$8,350.00
BUY
27 Sep 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
400,600
+0%
1,700
$1.69
$2,877.08
BUY
22 Sep 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,780,000
+0%
17,311
$1.73
$29,942.84
BUY
22 Sep 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
267,518
+1%
5,000
$1.76
$8,800.00
BUY
20 Sep 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
385,000
+2%
10,000
$1.85
$18,524.00
BUY
12 Sep 2022
Brown Scott B.
Chief Financial Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
14,628
+20%
2,500
$2.02
$5,037.50
BUY
26 Jul 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
370,000
+0%
2,254
$1.72
$3,876.88
BUY
22 Jul 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
262,518
+1%
4,500
$1.85
$8,325.00
BUY
15 Jul 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
367,746
+3%
11,826
$1.78
$21,068.02
BUY
14 Jul 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
355,920
+2%
7,187
$1.81
$13,024.28
BUY
12 Jul 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
258,018
+2%
6,000
$1.86
$11,130.00
BUY
24 Jun 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
348,733
+3%
11,419
$1.39
$15,894.11
BUY
21 Jun 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,776,589
+28%
841,989
$1.31
$1,105,279.00
BUY
10 May 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,934,600
+0%
9,700
$1.76
$17,032.23
BUY
9 May 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
252,018
+4%
10,000
$1.85
$18,500.00
BUY
6 May 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
242,018
+1%
2,500
$1.97
$4,925.00
BUY
29 Apr 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,926,100
+0%
7,100
$1.98
$14,058.00
BUY
29 Apr 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
239,518
+2%
5,000
$1.97
$9,854.50
BUY
22 Apr 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,920,000
+1%
52,777
$2.23
$117,438.50
BUY
21 Apr 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
234,518
+1%
4,500
$2.30
$10,350.00
BUY
13 Apr 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,872,296
+0%
20,041
$2.50
$50,090.88
BUY
11 Apr 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,857,296
+0%
27,198
$2.46
$66,846.21
BUY
8 Apr 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
226,518
+0%
2,000
$2.50
$5,000.00
BUY
30 Mar 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
224,518
+1%
4,000
$2.70
$10,800.00
BUY
29 Mar 2022
Brown Scott B.
Chief Financial Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
8,628
+13%
1,000
$2.82
$2,820.00
BUY
21 Mar 2022
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
220,518
+0%
1,200
$2.45
$2,940.00
BUY
16 Mar 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
("TCON")
2,837,735
+0%
2,235
$2.20
$4,917.00
BUY
28 Jan 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,820,500
+0%
500
$2.20
$1,100.00
BUY
21 Jan 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,835,000
+1%
52,363
$2.15
$112,413.83
BUY
19 Jan 2022
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,790,000
+1%
45,000
$2.25
$101,032.07
BUY
29 Dec 2021
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,750,000
+1%
52,325
$2.51
$131,361.90
BUY
27 Dec 2021
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,717,675
+4%
107,450.305
$2.87
$308,052.20
BUY
1 Dec 2021
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,517,371
+0%
21,964
$2.43
$53,286.86
BUY
1 Dec 2021
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,497,371
+2%
57,204
$2.56
$146,497.77
BUY
1 Dec 2021
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,448,371
+4%
112,007
$2.29
$256,384.94
BUY
1 Dec 2021
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,348,371
+2%
60,500
$2.39
$144,820.30
BUY
18 Nov 2021
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
219,318
+1%
4,181
$2.83
$11,831.28
BUY
5 Nov 2021
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
212,137
+1%
4,000
$3.41
$13,655.00
BUY
16 Aug 2021
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
207,732
+1%
3,000
$3.56
$10,680.00
BUY
13 Aug 2021
Brown Scott B.
Chief Financial Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
7,628
+15%
1,000
$3.69
$3,694.60
BUY
26 Jul 2021
PELLETIER SAUNDRA L
Director
Tracon Pharmaceuticals, Inc.
(TCON)
12,045
+119%
6,545
$3.82
$25,001.90
BUY
26 Jul 2021
LARUE WILLIAM R
Director
Tracon Pharmaceuticals, Inc.
(TCON)
7,883
+489%
6,545
$3.82
$25,001.90
BUY
8 Mar 2021
Brown Scott B.
Chief Financial Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
3,128
+46%
1,000
$8.30
$8,295.60
BUY
27 Jan 2021
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
201,232
+5%
11,000
$8.98
$98,771.20
BUY
30 Dec 2020
Ikarian Capital, LLC
10% Owner, Member of 10% Group
Tracon Pharmaceuticals, Inc.
(TCON)
2,716,840
+23%
520,291
$9.61
$4,999,996.50
BUY
29 Dec 2020
WIGGINS MARK C
Chief Business Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
13,697
+7%
1,000
$10.57
$10,569.97
BUY
29 Dec 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
190,232
+0%
1,000
$9.98
$9,980.00
BUY
22 Dec 2020
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
("TCON")
2,293,371
+27%
496,277
$8.06
$3,999,992.80
BUY
29 Oct 2020
Ikarian Capital, LLC
10% Owner, Member of 10% Group
Tracon Pharmaceuticals, Inc.
(TCON)
2,196,549
+1%
34,000
$5.10
$173,269.16
BUY
21 Oct 2020
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
225,000
+4%
8,656
$4.40
$38,059.57
BUY
21 Oct 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
189,232
+1%
2,000
$4.38
$8,769.00
BUY
23 Sep 2020
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
228,000
+52%
78,734
$4.73
$372,095.20
BUY
23 Sep 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
186,775
+2%
5,000
$4.72
$23,599.03
BUY
10 Sep 2020
WIGGINS MARK C
Chief Business Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
12,350
+130%
7,000
$4.14
$28,952.70
BUY
4 Sep 2020
Ikarian Capital, LLC
10% Owner, Member of 10% Group
Tracon Pharmaceuticals, Inc.
(TCON)
2,162,549
+17%
322,471
$3.28
$1,057,386.80
BUY
4 Sep 2020
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
225,266
+33%
56,558
$3.38
$190,902.36
BUY
4 Sep 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
176,882
+5%
10,000
$2.57
$25,750.00
BUY
1 Sep 2020
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
222,200
+256%
159,800
$2.28
$363,825.12
BUY
27 Aug 2020
Opaleye Management Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
1,352,346
+67%
545,504
$1.74
$950,377.94
BUY
21 Aug 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
171,882
+3%
5,325
$1.56
$8,307.00
BUY
20 Aug 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
166,557
+21%
30,000
$1.58
$47,400.00
BUY
14 Aug 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
136,557
+48%
44,843
$1.63
$73,020.70
BUY
12 Aug 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
91,714
+27%
20,000
$1.72
$34,500.00
BUY
24 Jun 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
71,714
+16%
9,895
$1.90
$18,800.50
BUY
10 Jun 2020
PELLETIER SAUNDRA L
Director
Tracon Pharmaceuticals, Inc.
(TCON)
5,500
+100%
5,500
$2.04
$11,209.10
BUY
22 May 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
61,227
+20%
10,592
$1.90
$20,118.88
BUY
13 Mar 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
50,877
+8%
4,100
$1.13
$4,624.39
BUY
11 Mar 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
41,777
+91%
20,000
$1.43
$28,639.00
BUY
10 Mar 2020
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
26,777
+59%
10,000
$1.87
$18,691.00
BUY
23 Jan 2020
WIGGINS MARK C
Chief Business Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
5,000
+100%
5,000
$4.02
$20,102.50
SELL
5 Dec 2019
Puissance Cross-Border Opportunities V LLC
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
76,048
-83%
384,130
$2.93
$1,127,379.10
BUY
9 Aug 2019
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
173,565
+2%
5,000
$4.50
$22,500.00
BUY
21 Dec 2018
THEUER CHARLES
President and CEO, Director, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
132,855
+3%
4,900
$6.58
$32,222.40
BUY
29 Nov 2018
Puissance Cross-Border Opportunities V LLC
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
4,606,094
+0%
865.2
$11.70
$10,122.84
BUY
27 Mar 2018
Sonsini Peter W.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
Viswanathan Ravi
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
SANDELL SCOTT D
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
MOTT DAVID M
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
KERINS PATRICK J
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
Florence Anthony A. Jr.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
BASKETT FOREST
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
BARRIS PETER J
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
BARRETT M JAMES
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
BUY
27 Mar 2018
New Enterprise Associates 14, L.P.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
3,466,003
+2%
70,796.4
$27.00
$1,911,502.90
SELL
2 Jun 2017
LARUE WILLIAM R
Director
Tracon Pharmaceuticals, Inc.
(TCON)
13,388
-1%
250
$26.93
$6,732.50
BUY
29 Nov 2016
Sonsini Peter W.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
New Enterprise Associates 14, L.P.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
BARRIS PETER J
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
MOTT DAVID M
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
KOLLURI KRISHNA KITTU
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
SANDELL SCOTT D
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
KERINS PATRICK J
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
Viswanathan Ravi
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
Florence Anthony A. Jr.
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
BASKETT FOREST
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
BUY
29 Nov 2016
BARRETT M JAMES
10% Owner
Tracon Pharmaceuticals, Inc.
(TCON)
2,758,039
+3%
86,956.5
$57.50
$4,999,999.00
SELL
3 Jun 2016
SHAZER RONALD L
Chief Medical Officer, Officer
Tracon Pharmaceuticals, Inc.
(TCON)
335
-23%
100.3
$74.80
$7,502.44
Home